Graham Reeve - Nov 15, 2023 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)

Role: COO
Signature: /s/ Graham Reeve
Stock symbol: USPH
Transactions as of: Nov 15, 2023
Transactions value $: -$131,085
Form type: 4
Date filed: 11/16/2023, 05:42 PM
Previous filing: Aug 14, 2023
Next filing: Feb 28, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	USPH	Common Stock	Sale	-$131K	-1.5K	-16.13%	$87.39	7.8K	Nov 15, 2023	Reeve Trust	F2
holding	USPH	Common Stock						11.9K	Nov 15, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 11,890 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,730 shares on January 1, 2024; 1,286 shares on each of April 1, 2024, July 1, 2024, October 1, 2024, and January 1, 2025; 936 shares on each of April 1, 2025, July 1, 2025 and October 1, 2025; 952 shares on January 1, 2026; and 312 shares on each of April 1, 2026, July 1, 2026 and October 1, 2026; and the final 320 shares on January 1, 2027, if he is an employee of the Company on those dates.
F2	The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.02 to $87.54, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Content

Includes 11,890 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,730 shares on January 1, 2024; 1,286 shares on each of April 1, 2024, July 1, 2024, October 1, 2024, and January 1, 2025; 936 shares on each of April 1, 2025, July 1, 2025 and October 1, 2025; 952 shares on January 1, 2026; and 312 shares on each of April 1, 2026, July 1, 2026 and October 1, 2026; and the final 320 shares on January 1, 2027, if he is an employee of the Company on those dates.

The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.02 to $87.54, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.